Project Oncology®

About Project Oncology®

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Publisher

ReachMD

Language

en

Explicit

No

First episode

31 Aug 2015

Latest episode

13 Oct 2026

Latest episodes

295 episodes in the feed.

1. 

   13 Oct 2026

   Sequencing Decisions in R/R LBCL: CAR T-Cell Therapy and Bispecific Antibodies

   Host: Steve Jackson, PharmD Guest: Paolo F. Caimi, MD Guest: Narendranath Epperla, MD, MS As both CAR T-cell therapy and bispecific antibodies become increasingly integrated into the treatment of R/R LBCL, it’s important to consider the evidence in the context of individual patient factors and disease characteristics. In this conversation with Dr. Steve Jackson, Dr. Paolo Caimi and Dr. Naren Epperla examine the evidence guiding these approaches and discuss how they think about sequencing decisions in these patients. Dr. Caimi is the Associate BMT Director for Cellular Therapy at the Cleveland Clinic Cancer Institute and an Associate Professor in the Department of Medicine at the Case Western Reserve University School of Medicine. Dr. Epperla is an Associate Professor of Medicine and Associate Chief of Clinical Research in the Division of Hematology at the University of Utah Huntsman Cancer Institute. This is a non-certified educational series produced and controlled by ReachMD.

2. 

   5 Oct 2026

   From Durability to Discovery: Advances in ALK+ mNSCLC Treatment

   Guest: Angel Qin, MD The treatment landscape for ALK+ metastatic non-small cell lung cancer (mNSCLC) is continuing to evolve, with durable outcomes from frontline ALK inhibition and emerging therapies offering new possibilities across disease settings. Join Dr. Angel Qin, Clinical Associate Professor of Internal Medicine at the University of Michigan Medical School, as she examines the evidence on current and emerging treatment options for this population.

3. 

   5 Oct 2026

   How Novel Strategies Could Push ALK+ mNSCLC Care Forward

   Guest: Angel Qin, MD Even with increasingly effective targeted therapies for ALK+ metastatic non-small cell lung cancer (mNSCLC), unanswered questions remain, especially when a patient's disease progresses or treatment becomes difficult to tolerate. In this program, Dr. Angel Qin looks beyond current care strategies to consider where the field is headed, from overcoming resistance to investigating entirely different ways of extending disease control. Dr. Qin is a Clinical Associate Professor of Internal Medicine at the University of Michigan Medical School.

Who has been a guest on Project Oncology®

Names identified in recent episode analyses. Showing up to five guests.

• Lisa Carter-Bawa
• Jonathon B Cohen
• Triparna Sen
• Loretta J Nastoupil
• Manali Kamdar

Reach and audience

Public platform figures. Ratings count people who left a rating, not total listeners.

Apple Podcasts (US)

4.5 / 5

2 ratings

Spotify

5.0 / 5

4 ratings

Podcast Authority Score: 28 / 100

A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.

Quality

22

Social presence

0

YouTube

0

Engagement

85

Contact Project Oncology®

Guest appearances

Books guests

Based on episode analysis; this does not confirm that the show is currently accepting guests.

Questions about Project Oncology®